OYSTER PT PHARMA INC's ticker is OYST and the CUSIP is 69242L106. A total of 71 filers reported holding OYSTER PT PHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $1,005,000 | -84.1% | 232,267 | -57.1% | 0.00% | -100.0% |
Q1 2022 | $6,303,000 | -48.6% | 541,454 | -19.3% | 0.00% | -50.0% |
Q4 2021 | $12,255,000 | +74.0% | 671,120 | +12.9% | 0.00% | +100.0% |
Q3 2021 | $7,042,000 | -83.0% | 594,311 | -75.3% | 0.00% | -85.7% |
Q2 2021 | $41,349,000 | +1.3% | 2,405,417 | +7.7% | 0.01% | 0.0% |
Q1 2021 | $40,828,000 | +44.5% | 2,233,498 | +48.7% | 0.01% | +40.0% |
Q4 2020 | $28,259,000 | -6.2% | 1,501,545 | +5.2% | 0.01% | -16.7% |
Q3 2020 | $30,124,000 | -46.3% | 1,426,971 | -26.6% | 0.01% | -50.0% |
Q2 2020 | $56,141,000 | +165.0% | 1,943,941 | +221.2% | 0.01% | +100.0% |
Q1 2020 | $21,183,000 | +83.4% | 605,224 | +28.1% | 0.01% | +200.0% |
Q4 2019 | $11,551,000 | – | 472,603 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Invus Financial Advisors, LLC | 2,768,586 | $50,554,000 | 15.36% |
KPCB XIV Associates, LLC | 367,987 | $6,719,000 | 4.17% |
NEA Management Company, LLC | 5,925,287 | $108,196,000 | 2.19% |
Paradigm Biocapital Advisors LP | 304,238 | $5,555,000 | 1.59% |
Sio Capital Management, LLC | 181,857 | $3,321,000 | 1.00% |
COWEN AND COMPANY, LLC | 509,794 | $9,309,000 | 0.84% |
RTW INVESTMENTS, LP | 2,058,504 | $37,588,000 | 0.55% |
ACT CAPITAL MANAGEMENT, LLC | 13,500 | $247,000 | 0.18% |
COOPER CREEK PARTNERS MANAGEMENT LLC | 79,510 | $1,452,000 | 0.17% |
Point72 Asset Management, L.P. | 2,101,441 | $38,372,000 | 0.15% |